Baxter International Inc. (BAX) EPS Estimated At $0.58

January 16, 2018 - By Richard Conner

 Baxter International Inc. (BAX) EPS Estimated At $0.58
Investors sentiment increased to 0.97 in Q3 2017. Its up 0.05, from 0.92 in 2017Q2. It is positive, as 38 investors sold Baxter International Inc. shares while 300 reduced holdings. 76 funds opened positions while 253 raised stakes. 439.80 million shares or 0.96% less from 444.08 million shares in 2017Q2 were reported.
Starboard Value Lp invested in 1.36 million shares. First Financial Bank Of Omaha has 92,043 shares for 0.35% of their portfolio. 174,857 are owned by Highbridge Cap Mngmt Ltd Limited Liability Company. Atlantic Grp Inc accumulated 0.02% or 58,108 shares. Peapack Gladstone invested in 0.04% or 11,069 shares. Mutual Of America Management Limited Com, New York-based fund reported 60,875 shares. Dekabank Deutsche Girozentrale holds 184,850 shares. Buckingham Cap Mgmt has invested 0.1% in Baxter International Inc. (NYSE:BAX). Da Davidson And reported 30,425 shares. 6,989 were accumulated by West Oak Limited Co. Baldwin Brothers Inc Ma owns 50 shares or 0% of their US portfolio. Clinton has invested 0.66% of its portfolio in Baxter International Inc. (NYSE:BAX). Schwab Charles Investment Mgmt has invested 0.14% in Baxter International Inc. (NYSE:BAX). State Teachers Retirement Sys reported 882,089 shares stake. 13,504 were accumulated by Leavell Mgmt.

Since August 17, 2017, it had 0 buys, and 4 insider sales for $2.16 million activity. 8,920 shares were sold by STALLKAMP THOMAS T, worth $555,538 on Tuesday, September 5. On Thursday, August 17 the insider Accogli Giuseppe sold $772,363. 4,020 Baxter International Inc. (NYSE:BAX) shares with value of $247,672 were sold by Shapazian Carole J.

Analysts expect Baxter International Inc. (NYSE:BAX) to report $0.58 EPS on February, 7.They anticipate $0.01 EPS change or 1.75 % from last quarter’s $0.57 EPS. BAX’s profit would be $316.00 million giving it 29.46 P/E if the $0.58 EPS is correct. After having $0.64 EPS previously, Baxter International Inc.’s analysts see -9.38 % EPS growth. The stock decreased 0.18% or $0.12 during the last trading session, reaching $68.34. About 2.37M shares traded. Baxter International Inc. (NYSE:BAX) has risen 32.55% since January 16, 2017 and is uptrending. It has outperformed by 15.85% the S&P500.

Baxter International Inc. (NYSE:BAX) Ratings Coverage

Among 18 analysts covering Baxter International (NYSE:BAX), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Baxter International had 49 analyst reports since July 30, 2015 according to SRatingsIntel. As per Friday, April 28, the company rating was maintained by BMO Capital Markets. The rating was reinitiated by Credit Suisse with “Neutral” on Monday, August 10. BMO Capital Markets maintained the shares of BAX in report on Monday, November 13 with “Buy” rating. Evercore initiated the stock with “Buy” rating in Wednesday, May 4 report. The firm has “Equal-Weight” rating by Morgan Stanley given on Tuesday, July 25. As per Tuesday, August 11, the company rating was maintained by Barclays Capital. On Tuesday, January 2 the stock rating was upgraded by Bank of America to “Buy”. The stock of Baxter International Inc. (NYSE:BAX) has “Hold” rating given on Friday, October 13 by Cowen & Co. On Monday, June 6 the stock rating was reinitiated by JP Morgan with “Neutral”. The stock of Baxter International Inc. (NYSE:BAX) earned “Hold” rating by S&P Research on Friday, July 31.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $37.23 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 36.58 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

More recent Baxter International Inc. (NYSE:BAX) news were published by: which released: “Baxter Launches Arisure Closed System Transfer Device to Help Prevent …” on January 11, 2018. Also published the news titled: “Baxter Announces Agreement to Broaden Portfolio of Innovative Surgical Products” on January 08, 2018.‘s news article titled: “Baxter (BAX) Launches Arisure Closed System Transfer Device” with publication date: January 15, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: